JNJ potential reversal! JNJ expected to rise up to 1st resistance at 133.95 where it could potentially react off and drop down to 1st support at 126.84. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. Shortby easyMarketsOct 14, 20197
Johnson & Johnson before Earnings(analysis per request, chart self-explanatory)Nby UnknownUnicorn5323213Oct 10, 20193
Sell Chanceentry to sell = if the green zone is broken down tp1 , tp2 is shown in fig sl = above the green zone ....... To receive notifications of entry to the position, join my channel : t.meNShortby techsxjjxjjAug 26, 201916
$JNJ SHORT targeting 126 then can be good bounce Bearish scenario for short term . long view remained bullish NShortby WinnerTrader99Updated Oct 9, 2019114
JNJ potential reversal! JNJ expected to rise up to 1st resistance at 138.94 where it could potentially react off and drop down to 1st support at 127.11. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. NShortby easyMarketsOct 3, 201911
JNJ approaching support, potential for a bounce! JNJ is expected to drop to 1st support at 125.01 where it could potentially react off and up to 1st resistance at 133.42. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. NLongby easyMarketsSep 30, 20197
Buying JNJ to target liquidityJNJ is being accumulated while there was divergency between the stock indicesNLongby hopiplaka1Sep 26, 20196
JNJ reversed from resistance, potential drop! JNJ reversed off its resistance at 132.32 where it could potentially drop further to 126.57. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. NShortby easyMarketsSep 26, 20196
JNJ reversed from resistance, potential drop! JNJ reversed off its resistance at 132.32 where it could potentially drop further to 126.57. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. NShortby easyMarketsSep 23, 20197
JNJ - created modern day nicotine?Called Norman "revolutionary type of poppy" and then marketed as a pain reliever. They totally knew what they were doing and it looks like they were on top of it all as the vertical integrator and setting up companies so as to not have it directly associated with JNJ. At the end of the day we may find out they actually supplied everyone including Purdue. Let's not forget they also have multiple jurisdiction lawsuits going against them on talcum powder and the fact they knew it was carcinogenic. So know 2 large cases of knowingly misleading the public. NShortby HatchetaxeSep 19, 20193
JNJ potential reversal! JNJ expected to rise up to 1st resistance at 132.32 where it could potentially react off and drop down to 1st support at 126.57. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. NShortby easyMarketsSep 19, 20196
Ranging Markets price is moving between support and resistance . we looking for buyers to push the stock upNLongby stroppycakes10Sep 17, 20193
JNJ approaching support, potential for a bounce! JNJ is expected to drop to 1st support at 129.46 where it could potentially react off and up to 1st resistance at 129.67. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. NLongby easyMarketsSep 17, 20199
JNJ potential reversal! JNJ expected to rise up to 1st resistance at 133.41 where it could potentially react off and drop down to 1st support at 126.99. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. NShortby easyMarketsSep 13, 20197
J&J vs opioids (Johnson is winning)Fundamental analysis In one of the first state opioid cases, an Oklahoma judge ruled against Johnson & Johnson, awarding the state $572 million, well below the over $17 billion the state was seeking in damages. Meaning... out of the 17 billion, they lost only 3.36%, and they expect to appeal the case, probably lowering this amount. Technical analysis On a technical analysis, I still think the risk reward ratio is too small to enter a position now. But technicals are good (not great). So I am keeping this on my watchlist. Nby dorfmanmasterSep 10, 20192
Johnson & Johnson updateRight shoulder worked well, now at a key weekly 200SMA. Further trade actions remain to be seen depending if we manage to close below the SMA. Move stops from shorts to capture profit. Overall still looks like a massive H&S setting up to break. Good Luck!Nby Antonio_traderSep 10, 20197
$JNJ bullish cypher pattern #Harmonics $JNJ bullish cypher pattern has entered the pattern reversal zone (D) long entry open w .618 target from the swing high (C) to the swing low (D) NLongby degenduccSep 5, 20193
JNJ, Johnson & Johnson - Potential Upward BreakoutNYSE:JNJ Do you know Johnson & Johnson? Top company in the Healthcare sector that is forming a zone of accumulation with potential upward breakage on this rising triangle and if so we would be interested in re-entering Long on this asset that we still have in our portfolio in the long term. Why Technical Analysis? Ask Peter Brandt...NLongby SwissTradingSchoolAug 31, 20191
DIRTY JUDGES & POLITICIANS. LAWSUITS SHOULD BE THROWN OUT!IT IS SIMPLY OUTRAGEOUS TO HOLD ANY PHARMACEUTICAL COMPANY LIABLE FOR SCRIPTS DOCTORS WROTE AND SCRIPTS THAT DRUG STORES / PHARMACIES FILLED BECAUSE OF THE DOCTORS NEGLIGENCE! WHY DON'T WE SEE CVS, WALGREENS AND WALMART LISTED AS DEFENDANTS? THEY KEPT FILLING SCRIPTS...DIDN'T ANY RED FLAGS FLASH ON THE SCREEN..? IN FACT, WHY DON'T WE SEE THE SALES REPS FOR THE PHARMACEUTICAL COMPANIES NAMED AS DEFENDANTS? THEY VISIT DOCTORS DAILY PUSHING THE DRUGS TO THEM! DOCTORS DO NOT HAVE TO WRITE SCRIPTS FOR PATIENTS BUT THEY DO AND THEY KNOW THE SIDE EFFECTS OF WHAT THEY ARE PRESCRIBING BECAUSE THE SALES REPS TELL THEM. WHY NOT SUE THE DOCTORS? THE DOCTORS, MANY, IF NOT ALL, ARE NOT INSURED NOR ARE THEY CASH RICH...ONE SMALL LAWSUIT WILL BANKRUPT THE ENTIRE INDUSTRY OF DOCTORS! THE CORRUPT STATES GO AFTER THE EASY MONEY BECAUSE THEY KNOW IN THE END, IT'S NOTHING BUT A SCAM. IT TURNS OUT TO BE A HUGE PR FIGHT TO RUIN BIG PHARMA SO THE PHARMACEUTICAL COMPANIES ARE AFRAID OF THEIR REPUTATIONS BEING RUINED & THEY CAVE IN AND SETTLE LIKE HENS IN A HEN HOUSE BUT THERE'S NOBODY LEFT TO COUNT THE CHICKENS! AS FOR THE STATES TRYING TO USE A LAW SIMILAR TO...READ ON... N. A STATUTE (DRAM SHOP ACT) OR CASE LAW IN 38 STATES WHICH MAKES A BUSINESS WHICH SELLS ALCOHOLIC DRINKS OR A HOST WHO SERVES LIQUOR TO A DRINKER WHO IS OBVIOUSLY INTOXICATED OR CLOSE TO IT, STRICTLY LIABLE TO ANYONE INJURED BY THE DRUNKEN PATRON OR GUEST. (DO YOU EVER SEE BIG LIQUOR COMPANIES SUED FOR DRUNK DRIVING FATALITIES..? NO, BECAUSE THEY CANNOT WIN!) THIS IN ITSELF IS OUTRAGEOUS AND SHOULD NOT STAND IN A LAWFUL COURT OF LAW! THE CASES / LAWSUITS AGAINST THE BIG PHARMACEUTICALS ARE VOID OF FACT AND EVIDENCE! THE PHARMACEUTICAL COMPANIES DON'T EVEN KNOW THE VICTIMS! WE FEEL BAD FOR THE FAMILIES THAT LOST LOVED ONES BUT TO GO AFTER THE PHARMACEUTICAL COMPANIES FOR SOMETHING A DRUG DEALER SOLD, A SCRIPT A DOCTOR WROTE OR A PHARMACY FILLED, IS SIMPLY CONTEMPTIBLE AND DISGUSTING! USE THE WEAKNESS TO LOAD UP / PICK ON DIPS, BIG NAME PHARMACEUTICAL STOCKS INVOLVED WITH THIS OUTRAGEOUS UNLAWFUL MESS! DON'T GO ALL IN UNTIL THIS MESS IS OVER! BUY THE DIPS...KEEP LOWERING YOUR COST BASIS WHEN A GOOD DIP HAPPENS. DISCLAIMER This website and our posts are for general information only. No information, forward looking statements, or estimations presented herein represent any final determination on investment performance. While the information presented in this website and our posts has been researched and is thought to be reasonable and accurate, any investment is speculative in nature. StockKid, and/or our agents cannot and do not guarantee any rate of return or investment timeline based on the information presented herein. By reading and reviewing the information contained in this website and our posts, the user acknowledges and agrees that StockKid, and/or our agents do not assume and hereby disclaim any liability to any party for any loss or damage caused by the use of the information contained herein, or errors or omissions in the information contained in this website or our posts, to make any investment decision, whether such errors or omissions result from negligence, accident or any other cause. Investors are required to conduct their own investigations, analysis, due diligence, draw their own conclusions, and make their own decisions. Any areas concerning taxes or specific legal or technical questions should be referred to lawyers, accountants, consultants, brokers, or other professionals licensed, qualified or authorized to render such advice. In no event shall StockKid, and/or our agents be liable to any party for any direct, indirect, special, incidental, or consequential damages of any kind whatsoever arising out of the use of this website, our posts or any information contained herein. StockKid, and/or our agents specifically disclaim any guarantees, including, but not limited to, stated or implied potential profits, rates of return, or investment timelines discussed or referred to herein. NLongby UnknownUnicorn3159981Aug 28, 20196
$JNJ Could be heading for a run soon - Watch outTrump just talked about making a huge buy from JNJ. Potential tweet about it could lead to a run upside. NLongby eaojnr0202Updated Aug 27, 20191